Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel C Smith

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
BMC Cancer|October 11, 2014
Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcomaRobert J Canter, Erik Ames, Stephanie Mac, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2015
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypeErik Ames, Robert J Canter, Steven K Grossenbacher, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
BMC Cancer|October 11, 2014
Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcomaRobert J Canter, Erik Ames, Stephanie Mac, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2015
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypeErik Ames, Robert J Canter, Steven K Grossenbacher, et al.
Pageof 2